These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17923603)

  • 1. High-sensitivity C-reactive protein and prediction of nontraumatic fractures.
    Cheng HY
    Arch Intern Med; 2007 Oct; 167(18):2007; author reply 2007-8. PubMed ID: 17923603
    [No Abstract]   [Full Text] [Related]  

  • 2. [C-reactive protein and significance of its study in open diaphyseal fractures].
    Markova ON; Bazanova EB
    Ortop Travmatol Protez; 1971 Apr; 32(4):69-72. PubMed ID: 5561109
    [No Abstract]   [Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome.
    Rosolova H; Petrlova B; Simon J; Sifalda P; Sipova I
    Med Sci Monit; 2008 Aug; 14(8):CR411-5. PubMed ID: 18667998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein levels for early detection of postoperative infection after fracture surgery in 787 patients.
    Neumaier M; Scherer MA
    Acta Orthop; 2008 Jun; 79(3):428-32. PubMed ID: 18622849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables.
    Mazza A; Bendini MG; Cristofori M; Nardi S; Leggio M; De Cristofaro R; Giordano A; Cozzari L; Giordano G; Cappato R
    Europace; 2009 Jul; 11(7):902-9. PubMed ID: 19443431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
    J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity C-reactive protein for risk stratification in patients with heart failure.
    Bauters C; Lamblin N; de Groote P
    Am Heart J; 2008 Feb; 155(2):e7; author reply e9. PubMed ID: 18215583
    [No Abstract]   [Full Text] [Related]  

  • 10. The relation between high-sensitivity C-reactive protein and maximum body mass index in patients with psoriasis.
    Ohtsuka T
    Br J Dermatol; 2008 May; 158(5):1141-3. PubMed ID: 18284386
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of high-sensitivity C-reactive protein serum assay results obtained using Dade-Behring BNII nephelometer and Ortho Vitros FS 5.1 clinical analyzer in respect of CRP-related risk assessment of chronic metabolic diseases.
    Kusnierz-Cabala B; Gernand W; Zabek-Adamska A; Tokarz A; Naskalski JW
    Clin Lab; 2008; 54(9-10):341-6. PubMed ID: 19097491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
    Paraskevas KI; Bessias N; Papas TT; Andrikopoulos V; Mikhailidis DP
    Angiology; 2009; 60(1):8-11. PubMed ID: 19190029
    [No Abstract]   [Full Text] [Related]  

  • 14. Canine serum C-reactive protein detected by means of a near-patient test for human C-reactive protein.
    Kjelgaard-Hansen M; Stadler M; Jensen AL
    J Small Anim Pract; 2008 Jun; 49(6):282-6. PubMed ID: 18422504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women.
    Cauci S; Di Santolo M; Culhane JF; Stel G; Gonano F; Guaschino S
    Obstet Gynecol; 2008 Apr; 111(4):857-64. PubMed ID: 18378744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Tohidi M; Hadaegh F; Harati H; Azizi F
    Int J Cardiol; 2009 Mar; 132(3):369-74. PubMed ID: 18242731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood protein picture in fractures].
    DELLA CORTE M
    Policlinico Chir; 1958 Oct; 65(5):291-304. PubMed ID: 13633498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.